Estimate Recalculated Apr 1, 2025 09:49PM EST
James R Meyers has an estimated net worth of $11.7 Million. This is based on reported shares across multiple companies, which include GILEAD SCIENCES INC, SANGAMO THERAPEUTICS, INC, Arbutus Biopharma Corp, and CytomX Therapeutics, Inc..
James R Meyers's CIK is 0001387521
2017 was James R Meyers's most active year for acquiring shares with 9 total transactions. James R Meyers's most active month to acquire stocks was the month of January. 2007 was James R Meyers's most active year for disposing of shares, totalling 18 transactions. James R Meyers's most active month to dispose stocks was the month of March. 2018 saw James R Meyers paying a total of $2,171,278.80 for 254,138 shares, this is the most they've acquired in one year. In 2018 James R Meyers cashed out on 203,970 shares for a total of $8,157,260.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!